Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

CENTRIFUGATION IN GP PRACTICES - CAN IT IMPROVE DIAGNOSTIC EFFICIENCY?

Coffey W, Magee B, Harris J, Edwards R, McKillop D.

Ulster Med J. 2018 Jan;87(1):52-53. Epub 2018 Jan 31. No abstract available.

2.

How financial strain affects health: Evidence from the Dutch National Bank Household Survey.

Prentice C, McKillop D, French D.

Soc Sci Med. 2017 Apr;178:127-135. doi: 10.1016/j.socscimed.2017.02.006. Epub 2017 Feb 14.

PMID:
28214723
3.
4.

Apologies following an adverse medical event: The importance of focusing on the consumer's needs.

Allan A, McKillop D, Dooley J, Allan MM, Preece DA.

Patient Educ Couns. 2015 Sep;98(9):1058-62. doi: 10.1016/j.pec.2015.06.001. Epub 2015 Jun 16.

PMID:
26138159
5.

A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.

Lee GR, Johnston PC, Atkinson AB, McKillop D, Auld P, Hunter SJ.

J Hypertens. 2011 Dec;29(12):2422-8. doi: 10.1097/HJH.0b013e32834c1e68.

PMID:
22002333
6.

The health implications of apologizing after an adverse event.

Allan A, McKillop D.

Int J Qual Health Care. 2010 Apr;22(2):126-31. doi: 10.1093/intqhc/mzq001. Epub 2010 Feb 5.

PMID:
20139148
7.

Response to Heijboer et al. Ann Clin Biochem 2009;46(3):263-4.

McKillop D, Thompson D, Sharpe P.

Ann Clin Biochem. 2009 Sep;46(Pt 5):428-9. doi: 10.1258/acb.2009.009144. No abstract available.

PMID:
19721093
8.

In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes.

McCormick AD, Slamon DL, Lenz EM, Phillips PJ, King CD, McKillop D, Roberts DW.

Xenobiotica. 2007 Sep;37(9):972-85.

PMID:
17896324
9.

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase.

Mortlock AA, Foote KM, Heron NM, Jung FH, Pasquet G, Lohmann JJ, Warin N, Renaud F, De Savi C, Roberts NJ, Johnson T, Dousson CB, Hill GB, Perkins D, Hatter G, Wilkinson RW, Wedge SR, Heaton SP, Odedra R, Keen NJ, Crafter C, Brown E, Thompson K, Brightwell S, Khatri L, Brady MC, Kearney S, McKillop D, Rhead S, Parry T, Green S.

J Med Chem. 2007 May 3;50(9):2213-24. Epub 2007 Mar 21.

PMID:
17373783
10.

The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation.

McKillop DJ, McNulty H, Scott JM, McPartlin JM, Strain JJ, Bradbury I, Girvan J, Hoey L, McCreedy R, Alexander J, Patterson BK, Hannon-Fletcher M, Pentieva K.

Am J Clin Nutr. 2006 Jul;84(1):167-73.

PMID:
16825692
11.

The effect of serum creatinine method choice on estimated glomerular filtration rate determined by the abbreviated MDRD formula.

McKillop DJ, Cairns B, Duly E, Van Drimmelen M, Ryan M.

Ann Clin Biochem. 2006 May;43(Pt 3):220-2.

PMID:
16704759
12.

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition.

McKillop D, Guy SP, Spence MP, Kendrew J, Kemp JV, Bushby N, Wood PG, Barnett S, Hutchison M.

Xenobiotica. 2006 Jan;36(1):29-39.

PMID:
16507511
13.

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.

Swaisland HC, Ranson M, Smith RP, Leadbetter J, Laight A, McKillop D, Wild MJ.

Clin Pharmacokinet. 2005;44(10):1067-81.

PMID:
16176119
14.

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor.

McKillop D, Partridge EA, Kemp JV, Spence MP, Kendrew J, Barnett S, Wood PG, Giles PB, Patterson AB, Bichat F, Guilbaud N, Stephens TC.

Mol Cancer Ther. 2005 Apr;4(4):641-9.

15.

In vitro metabolism of gefitinib in human liver microsomes.

McKillop D, McCormick AD, Miles GS, Phillips PJ, Pickup KJ, Bushby N, Hutchison M.

Xenobiotica. 2004 Nov-Dec;34(11-12):983-1000.

PMID:
15801543
16.

Cytochrome P450-dependent metabolism of gefitinib.

McKillop D, McCormick AD, Millar A, Miles GS, Phillips PJ, Hutchison M.

Xenobiotica. 2005 Jan;35(1):39-50.

PMID:
15788367
17.

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man.

McKillop D, Hutchison M, Partridge EA, Bushby N, Cooper CM, Clarkson-Jones JA, Herron W, Swaisland HC.

Xenobiotica. 2004 Oct;34(10):917-34.

PMID:
15764411
18.

Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog.

McKillop D, Partridge EA, Hutchison M, Rhead SA, Parry AC, Bardsley J, Woodman HM, Swaisland HC.

Xenobiotica. 2004 Oct;34(10):901-15.

PMID:
15764410
19.

The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men.

Pentieva K, McNulty H, Reichert R, Ward M, Strain JJ, McKillop DJ, McPartlin JM, Connolly E, Molloy A, Krämer K, Scott JM.

J Nutr. 2004 Mar;134(3):580-5.

PMID:
14988450
20.

Acute absorption of folic acid from a fortified low-fat spread.

Pentieva K, McKillop D, Duffy N, de Deckere EA, Jacobs RG, van der Put NM, McNulty H.

Eur J Clin Nutr. 2003 Oct;57(10):1235-41.

PMID:
14506483
21.

Protocol for the production of concentrated extracts of food folate for use in human bioavailability studies.

McKillop DJ, Pentieva KD, Scott JM, Strain JJ, McCreedy R, Alexander J, Patterson K, Hughes J, McNulty H.

J Agric Food Chem. 2003 Jul 16;51(15):4382-8.

PMID:
12848514
22.

The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet.

McKillop DJ, Pentieva K, Daly D, McPartlin JM, Hughes J, Strain JJ, Scott JM, McNulty H.

Br J Nutr. 2002 Dec;88(6):681-8.

PMID:
12493090
23.

Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan.

Wild MJ, McKillop D, Butters CJ.

Xenobiotica. 1999 Aug;29(8):847-57.

PMID:
10553725
24.

Antioxidant status of oral mucosal tissue and plasma levels in smokers and non-smokers.

Cowan CG, Calwell EI, Young IS, McKillop DJ, Lamey PJ.

J Oral Pathol Med. 1999 Sep;28(8):360-3.

PMID:
10478961
25.

Preclinical and in vitro assessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions.

McKillop D, Back DJ, McCormick AD, Evans JA, Tjia J.

Xenobiotica. 1999 Apr;29(4):395-408.

PMID:
10375008
26.

Effects of propofol on human hepatic microsomal cytochrome P450 activities.

McKillop D, Wild MJ, Butters CJ, Simcock C.

Xenobiotica. 1998 Sep;28(9):845-53.

PMID:
9764927
27.

Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samples.

Boobis AR, McKillop D, Robinson DT, Adams DA, McCormick DJ.

Xenobiotica. 1998 May;28(5):493-506.

PMID:
9622851
28.

Enzyme-inducing effects of bicalutamide in mouse, rat and dog.

McKillop D, Butters CJ, Hill SJ, Simons PJ, Edwards TL, Doughty SE.

Xenobiotica. 1998 May;28(5):465-78.

PMID:
9622849
29.

Pharmacodynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog.

Poucher SM, Keddie JR, Brooks R, Shaw GR, McKillop D.

J Pharm Pharmacol. 1996 Jun;48(6):601-6.

PMID:
8832494
30.

Absence of hepatic enzyme induction in prostate cancer patients receiving 'Casodex' (bicalutamide).

Kaisary A, Klarskov P, McKillop D.

Anticancer Drugs. 1996 Jan;7(1):54-9.

PMID:
8742099
31.
32.

Enantioselective metabolism and pharmacokinetics of Casodex in the male rat.

McKillop D, Simons PJ, Cockshott ID, Hill SJ, Harding JR, Cooper KJ, Jones DC.

Xenobiotica. 1995 Jun;25(6):623-33.

PMID:
7483662
33.

The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.

McKillop DF, Fortune NS, Ranatunga KW, Geeves MA.

J Muscle Res Cell Motil. 1994 Jun;15(3):309-18.

PMID:
7929796
34.

GP training--screen test.

Ferguson C, Brown M, McKillop D, Bradley S.

Health Serv J. 1994 Jun 2;104(5405):22-3. No abstract available.

PMID:
10134888
35.

Metabolism and enantioselective pharmacokinetics of Casodex in man.

McKillop D, Boyle GW, Cockshott ID, Jones DC, Phillips PJ, Yates RA.

Xenobiotica. 1993 Nov;23(11):1241-53.

PMID:
8310708
36.

A woman with shock and normal cardiac output after acute MI.

Frierson J, Stiles W, McKillop D, Bain R.

Hosp Pract (Off Ed). 1993 Oct 30;28(10A):90-2. No abstract available.

PMID:
8408353
38.

Metabolism of Casodex in laboratory animals.

Boyle GW, McKillop D, Phillips PJ, Harding JR, Pickford R, McCormick AD.

Xenobiotica. 1993 Jul;23(7):781-98.

PMID:
8237060
39.

The effects on rat thyroid function of an hepatic microsomal enzyme inducer.

Johnson S, McKillop D, Miller J, Smith IK.

Hum Exp Toxicol. 1993 Mar;12(2):153-8.

PMID:
8096714
41.

The effect of hydrostatic pressure on the interaction of actomyosin subfragment 1 with nucleotides.

McKillop DF, Geeves MA, Balny C.

Biochem Biophys Res Commun. 1991 Oct 31;180(2):552-7.

PMID:
1835384
43.

Mutagenicity, carcinogenicity and toxicity of beta-naphthoflavone, a potent inducer of P448.

McKillop D, Case DE.

Biochem Pharmacol. 1991 Jan 1;41(1):1-7. Review. No abstract available.

PMID:
1986733
44.

Effect of phosphate and sulphate on the interaction of actin and myosin subfragment 1.

McKillop DF, Geeves MA.

Biochem Soc Trans. 1990 Aug;18(4):585-6. No abstract available.

PMID:
2276449
45.

The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboon.

McKillop D, Pickup KJ, Swaisland AJ, Holmes BF.

Xenobiotica. 1990 Apr;20(4):401-15.

PMID:
2346037
46.

A new method for extraction of iron-molybdenum cofactor (FeMoco) from nitrogenase adsorbed to DEAE-cellulose. 1. Effects of anions, cations, and preextraction treatments.

McLean PA, Wink DA, Chapman SK, Hickman AB, McKillop DM, Orme-Johnson WH.

Biochemistry. 1989 Nov 28;28(24):9402-6.

PMID:
2611239
47.
48.
49.

Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.

McKillop D, Bradford HF.

Biochem Pharmacol. 1981 Oct;30(20):2753-8. No abstract available.

PMID:
7317073
50.

Microsomal biophenyl hydroxylation: the effect of selective deuterium substitution on the rate of formation of the monohydroxybiphenyls [proceedings].

Bridges JW, McKillop D, Cox PJ, Farmer PB, Foster AB, Jarman M.

Biochem Soc Trans. 1979 Oct;7(5):1073-5. No abstract available.

PMID:
510705

Supplemental Content

Loading ...
Support Center